[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100432317":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":33,"responsibleParty":163,"collaborators":165,"id":180,"slug":181,"hasResults":182,"nctId":183,"briefTitle":184,"officialTitle":185,"acronym":186,"eligibilityCriteria":187,"healthyVolunteers":182,"sex":188,"minAge":189,"maxAge":10,"enrollmentInfo":190,"targetDuration":10,"studyType":193,"phases":10,"briefSummary":194,"conditions":195,"keywords":10,"overallStatus":84,"whyStopped":10,"lastUpdateSubmitDate":197,"lastUpdatePostDateStruct":198,"startDateStruct":201,"completionDateStruct":203,"leadSponsor":205,"locationsCount":206},{"fullName":5,"class":6},"Centre hospitalier de l'Université de Montréal (CHUM)","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patient with ureteral stent",null,"Patients with ureteral stent that meet the inclusion, exclusion criteria complete the Canadian Endourology Group Stent Symptom Score (CEGSSS)",[13],"Other: CEGSSS-Canadian Endourology Group Stent Symptom Score",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"CEGSSS-Canadian Endourology Group Stent Symptom Score","Patient with ureteral stent complete the Canadian Endourology Group Stent Symptom Score (CEGSSS)",[9],[20],{"name":21,"affiliation":5,"role":22},"Naeem Bhojani, MD","PRINCIPAL_INVESTIGATOR",[24,29],{"name":21,"role":25,"phone":26,"phoneExt":27,"email":28},"CONTACT","514-890-8000","14069","naeem.bhojani@gmail.com",{"name":30,"role":25,"phone":26,"phoneExt":31,"email":32},"Kahina Bensaadi, DESS","30824","kahina.bensaadi.chum@ssss.gouv.qc.ca",[34,52,66,82,102,116,130,140,153],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"University of California, Los Angeles","NOT_YET_RECRUITING","Los Angeles","California","90095","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-118.24368,34.05223,{"lat":46,"lon":45},[49],{"name":50,"role":25,"phone":10,"phoneExt":10,"email":51},"Kymora Scotland, MD","scotland.kb@gmail.com",{"facility":53,"status":36,"city":54,"state":55,"zip":56,"country":40,"countryCode":41,"cosmosGeoPoint":57,"geoPoint":61,"contacts":62},"Cleveland Clinic - University of Toronto.","Mayfield Heights","Ohio","44124",{"type":43,"coordinates":58},[59,60],-81.4579,41.51922,{"lat":60,"lon":59},[63],{"name":64,"role":25,"phone":10,"phoneExt":10,"email":65},"Sri Sivalingham, MD","sri.sivalingam@gmail.com",{"facility":67,"status":36,"city":68,"state":69,"zip":70,"country":71,"countryCode":72,"cosmosGeoPoint":73,"geoPoint":77,"contacts":78},"Alberta University - Northern Alberta Urology Centre","Edmonton","Alberta","T6G 1Z1","Canada","CA",{"type":43,"coordinates":74},[75,76],-113.46871,53.55014,{"lat":76,"lon":75},[79],{"name":80,"role":25,"phone":10,"phoneExt":10,"email":81},"Shubha De, MD","shubhade@gmail.com",{"facility":83,"status":84,"city":85,"state":86,"zip":87,"country":71,"countryCode":72,"cosmosGeoPoint":88,"geoPoint":92,"contacts":93},"Vancouver General Hospital","RECRUITING","Vancouver","British Columbia","V6X 1Z9",{"type":43,"coordinates":89},[90,91],-123.11934,49.24966,{"lat":91,"lon":90},[94,97],{"name":95,"role":25,"phone":10,"phoneExt":10,"email":96},"Ben Chew, MD","ben.chew@ubc.ca",{"name":98,"role":25,"phone":99,"phoneExt":100,"email":101},"Wong Victor, BSc.","604-875-4111","62421","kfvwong@alumni.ubc.ca",{"facility":103,"status":36,"city":104,"state":105,"zip":106,"country":71,"countryCode":72,"cosmosGeoPoint":107,"geoPoint":111,"contacts":112},"Dalhousie University","Halifax","Nova Scottia","B3H 1Y6",{"type":43,"coordinates":108},[109,110],-63.57688,44.64269,{"lat":110,"lon":109},[113],{"name":114,"role":25,"phone":10,"phoneExt":10,"email":115},"Andrea Lantz Powers, MD","andrea.lantz@gmail.com",{"facility":117,"status":36,"city":118,"state":119,"zip":120,"country":71,"countryCode":72,"cosmosGeoPoint":121,"geoPoint":125,"contacts":126},"St. Michael's Hospital - University of Toronto","Toronto","Ontario","M5B 1W8",{"type":43,"coordinates":122},[123,124],-79.39864,43.70643,{"lat":124,"lon":123},[127],{"name":128,"role":25,"phone":10,"phoneExt":10,"email":129},"Micheal Ordon, MD","michael.ordon@utoronto.ca",{"facility":131,"status":36,"city":118,"state":119,"zip":132,"country":71,"countryCode":72,"cosmosGeoPoint":133,"geoPoint":135,"contacts":136},"Toronto General Hospital - University Health Network (UHN)","M5G 2C4",{"type":43,"coordinates":134},[123,124],{"lat":124,"lon":123},[137],{"name":138,"role":25,"phone":10,"phoneExt":10,"email":139},"Jason Lee, MD","jasonleeuoft@gmail.com",{"facility":141,"status":84,"city":142,"state":143,"zip":144,"country":71,"countryCode":72,"cosmosGeoPoint":145,"geoPoint":149,"contacts":150},"Centre Hospitalier de l'Université de Montréal (CHUM)","Montreal","Quebec","H2X 3E4",{"type":43,"coordinates":146},[147,148],-73.58781,45.50884,{"lat":148,"lon":147},[151,152],{"name":21,"role":25,"phone":26,"phoneExt":27,"email":28},{"name":30,"role":25,"phone":26,"phoneExt":31,"email":32},{"facility":154,"status":36,"city":142,"state":143,"zip":155,"country":71,"countryCode":72,"cosmosGeoPoint":156,"geoPoint":158,"contacts":159},"Royal Victoria Hospital- McGill University Health Centre","H4A 3J1",{"type":43,"coordinates":157},[147,148],{"lat":148,"lon":147},[160],{"name":161,"role":25,"phone":10,"phoneExt":10,"email":162},"Sero Andonian, MD","Sero.Andonian@muhc.mcgill.ca",{"type":164,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[166,168,170,172,173,175,177,178],{"name":167,"class":6},"Université de Montréal",{"name":169,"class":6},"University of British Columbia",{"name":171,"class":6},"University of Toronto",{"name":103,"class":6},{"name":174,"class":6},"University of Alberta",{"name":176,"class":6},"McGill University",{"name":35,"class":6},{"name":179,"class":6},"University Health Network, Toronto","100432317","development-of-a-new-canadian-endourology-group-stent-symptom-score-100432317",false,"NCT04909541","Development of a New Canadian Endourology Group Stent Symptom Score","Canadian Endourology Group Stent Symptom Score: Development and Validation of A New Questionnaire","CEGSSS","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Patient with ureteral stent\n* Ability to communicate in English\n\nExclusion Criteria:\n\n* Inability to provide an informed consent due to physical or mental inability\n* Active malignancy\n* Obstruction\n* Long-term stent (\\>2 weeks)","ALL","18 Years",{"count":191,"type":192},180,"ESTIMATED","OBSERVATIONAL","Placement of a ureteral stent is a common urological intervention. For decades there was no valid measures available to assess quality of life issues in patients with ureteral stents, which has hampered the understanding of such symptoms and their true impact. In order to improve the outcomes associated with the placement of a stent, a validated tool is needed to measure its impact and the amount of undesirable effects it produces on patients requiring the placement of a stent. In 2003, the team of the Bristol Urological Institute developed a validated questionnaire called the: URETERAL STENT SYMPTOM QUESTIONNAIRE (USSQ). The questionnaire contains 38 items included in 6 sections. Despite the obvious need of a validated questionnaire, the latter remains unused by the community of peer urologists. Many of urologists consider it too long to be used in clinical practice and even for research purposes. This issue motivated the Canadian Endourology Group (CEG) to work collaboratively on the development of the CANADIAN ENDOUROLOGY GROUP STENT SYMPTOM SCORE (CEGSSS) in order to provide clinicians with a more useful and validated tool. To fulfill this objective, the CEG proceeds in three phases. Phase 1. A systematic, deliberative, and participatory approach mostly through face to face meetings, including patients, clinicians, and researchers in the field of Endourology to identify a minimum needs-based set of domains and items that are, clinically relevant to be included in the CEGSSS in order to ensure optimal uptake in the clinical setting. Phase 2. A pilot study to assess feasibility\u002Facceptability and further refine the proposed set of items selected in phase 1 of the study. Phase 3. A multicentric prospective study to evaluate the validity, reliability and sensitivity to change of the CEGSSS.\n\nThis research project is conducted by the Canadian Endourology Group (CEG), a panel of experts in the field of endourology in Canada. The CEG is a national member-based organization dedicated to enabling the profession to provide the highest possible standards of endourological care and to advance the science of endourology by collaboratively:\n\n1. Fostering excellence in endourological practice through advocacy, education, research and practice support tools,\n2. Leading evidence-based clinical practice through the development of practice standards and guidelines in endourology,\n3. Providing continuous professional development for Canadian endourologists along the career-path continuum,\n4. Providing leadership in public education for endourological conditions.",[196],"Urologic Diseases","2024-06-06",{"date":199,"type":200},"2024-06-07","ACTUAL",{"date":202,"type":200},"2022-05-15",{"date":204,"type":192},"2025-09-15",{"name":5,"class":6},9]